Eversheds Sutherland has advised Azurity Pharmaceuticals. Azurity Pharmaceuticals has expanded its product portfolio through the acquisition of CONTRAVE® and related assets, furthering the company’s strategy in...
Azurity Pharmaceuticals Acquires CONTRAVE® and Related Assets to Expand Portfolio
Azurity Pharmaceuticals’ Acquisition of Covis Pharma
White & Case served as legal advisors to Azurity, and Wilson Sonsini Goodrich & Rosati advised Azurity on litigation matters related to the transaction. Reed Smith...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Azurity Pharmaceuticals v. Edge Pharma
ArentFox Schiff secured an important victory for Azurity Pharmaceuticals, Inc. when the US Court of Appeals for the First Circuit found that the Food, Drug, and...
Azurity’s Acquisition of Arbor Pharmaceuticals
Wilson Sonsini Goodrich & Rosati and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Azurity on the deal while King & Spalding represented Arbor Pharmaceuticals. Azurity...